Clinical Trial Update: Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing microbiologic response in ventilator-associated pneumonia due to MRSA treated with linezolid and vancomycin (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Linezolid (Linezolid)
• Vancomycin (vancomycin)

Snippet

Sponsor: Pfizer | Conditions: Pneumonia, Ventilator-Associated | Phase 4 | Status: COMPLETED